RadNet, Inc. (RDNT) Q3 FY2026 earnings

Reported results

• Total Company Revenue increased 22.1% to $638.3 million in the third quarter of 2026 from $522.9 million in the third quarter of 2025.
• Non-GAAP Total Company Adjusted EBITDA was $105.0 million in the third quarter of 2026 compared with $84.9 million in the third quarter of 2025, an increase of 23.8%.
• GAAP Total Company Net Income was $4.2 million for the third quarter of 2026 compared with $5.4 million for the third quarter of 2025.
• GAAP fully diluted Net Income Per Share was $0.05 for the third quarter of 2026 compared with $0.07 in the third quarter of 2025.
• Non-GAAP Adjusted Diluted Earnings Per Share was $0.30 for the third quarter of 2026 compared with $0.24 for the third quarter of 2025.

Guidance

• For full-year 2026, revised Imaging Center Segment guidance includes Total Net Revenue of $2,385 - $2,435 million, Adjusted EBITDA of $350 - $363 million, Capital Expenditures of $170 - $180 million, Cash Interest Expense of $48 - $53 million, and Free Cash Flow of $120 - $130 million.
• For full-year 2026, revised Digital Health Segment guidance includes Total Net Revenue (inclusive of intersegment revenue) of $135 - $145 million, Adjusted EBITDA Before Non-Capitalized R&D - DeepHealth Cloud OS & Generative AI of $11 - $13 million, and Free Cash Flow After Non-Capitalized R&D - DeepHealth Cloud OS & Generative AI of $(17) - $(19) million.

Notes

Adjusted Diluted Earnings Per Share for the third quarter of 2025 was adjusted from what was reported last year to reflect additional addbacks of $1,042,000 for loss/gain on equipment disposal and $3,353,000 for Digital Health segment intangibles amortization expense.

Price and volatility reaction

The stock moved +3.1% on the print. No front-expiry chain was on file, so there is no straddle expected move.

Source

The figures above come from the earnings release the company filed with the SEC on 2026-11-09 (8-K, Item 2.02). Read the original filing on sec.gov.